Search

everythinglearnresearchcommunity

for

Search:↓

The LncRNA AC010789.1 slows down hair loss by promoting hair follicle growth and interacting with miR-21 and the Wnt/β-catenin pathway.

Long-term Finasteride treatment reduces depression better than short-term treatment in rats.

Emotional Freedom Techniques (EFT) treatment improved seed germination and growth, suggesting mood affects seed viability.

Finasteride treatment in male rats causes long-lasting effects on depression-like behavior, brain cell growth, inflammation, and gut bacteria composition.

Long-term finasteride treatment reduces depression and brain issues in obese male rats.

Depression in women with Polycystic Ovarian Syndrome (PCOS) is linked to insulin resistance and hyperandrogenism, and managing these can help reduce depression. Lifestyle changes and Cognitive Behavioral Therapy can be effective treatments.

Adverse events in lung cancer treatments increase fear, anxiety, and depression, with newer therapies causing fewer side effects.

Gut flora changes could potentially indicate depression, but more research is needed.

Melatonin may help with sleep issues, depression, and cancer, but more research is needed.

Finasteride and dutasteride effectively treat hair loss in men and women, but may cause side effects like low libido and depression.

Some men taking finasteride for hair loss experienced anxiety, depression, and sexual problems, which sometimes continued after stopping the medication.

Mindfulness reduces anxiety and depression in skin disease patients; dermatologists and psychiatrists often lack confidence in treating psychodermatological conditions.

Primary healthcare clinics are key in managing chemotherapy side effects using various medications and treatments.

Finasteride treats enlarged prostate and hair loss, but may cause side effects in some patients.

Neurosteroids can influence behavior by modulating brain inhibition, with potential for treating psychiatric disorders.

The conclusion is that careful management of both psychiatric and skin conditions is crucial for HIV patients, using medication and interdisciplinary approaches.

Inositol was not more effective than a placebo in treating trichotillomania.

The document concludes that there is hope for future psychopharmacology research despite challenges in treating schizophrenia.

The article suggests managing interferon beta therapy side effects in MS with dose adjustments, medications, and patient education.

St. John's Wort extract and oil safety in cosmetics is unclear; more data needed on photosensitization, toxicity, and human irritation.

Some patients taking finasteride or dutasteride may have ongoing sexual problems and depression even after stopping the medication.

A woman with anorexia and Cushing's syndrome improved after tumor removal, highlighting the need to consider hormonal issues in psychiatric conditions.

Family-based treatment is the best outpatient care for stable teens with anorexia, and more research is needed on medication and treatment effectiveness for young people with eating disorders.

Combining mood stabilizers with antipsychotics is more effective for treating children with bipolar disorder than using mood stabilizers alone.

Zinc helps reduce the severity of depression.

PDE inhibitors, especially PDE4 inhibitors like apremilast, are effective for certain inflammatory skin conditions but have side effects and can be costly.

DHEA did not improve sexual function, well-being, or menopausal symptoms in postmenopausal women with low libido but caused side effects like acne and increased facial hair.

Oral estradiol works for many transgender women but needs personalized dosing and monitoring.

Ixekizumab successfully treated a rare hair loss condition, leading to complete hair regrowth.

New acne treatments include combination creams, advanced retinoids, and light therapies, focusing on safety and patient adherence.